查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1964106

十字韧带修復手术市场 - 全球产业规模、份额、趋势、机会、预测：按手术类型、最终用途、地区和竞争格局划分，2021-2031年

Cruciate Ligament Repair Procedures Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Procedure Type, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球十字韧带修復手术市场预计将从 2025 年的 150.6 亿美元成长到 2031 年的 223.6 亿美元，复合年增长率为 6.81%。

これらの外科的介入は、自体骨移植、同种移植片、または合成代替物を用いて损伤した膝の前十字韧帯または后十字韧帯を重组し、関节の安定性を回復することを目的としております。本市场の成长は主に、スポーツ関连损伤の増加倾向と、一般人口における高负荷身体活动への参加率上昇によって牵引されております。例えば、ニュージーランド前十字韧帯登録机构（ACL Registry）の2024年报告によれば、ラグビーは依然として患者における损伤の主要原因であり、症例の23%を占めており、コンタクトスポーツと重组手术の需要との直接的な関连性を浮き雕りにしています。さらに、低侵袭技术や移植片固定技术の进歩は、患者の治疗成果を向上させることで、市场の成长を継続的に支えています。

市场概览
预测期 2027-2031
市场规模：2025年 150.6亿美元
市场规模：2031年 223.6亿美元
复合年增长率：2026-2031年 6.81%
成长最快的细分市场 前十字韧带修復
最大的市场 北美洲

然而，市场扩张的一大障碍是这些复杂手术及术后復原的高昂费用。许多医疗体系的保险覆盖范围有限，造成了经济壁垒，使患者无法获得先进的治疗方案。此外，诸如移植失败和感染等併发症的潜在风险需要严格的长期管理，这可能会让对费用敏感的患者望而却步。这些经济因素阻碍了十字韧带修復方案的广泛应用，尤其是在发展中国家。

市场驱动因素

高强度运动伤害的发生率不断上升，这主要归因于运动参与度的活性化和现代运动竞争的加剧，也是推动十字韧带（ACL）修復市场扩张的主要因素。这一趋势在女性运动员中尤其明显，她们在足球、篮球等需要频繁转体的运动中，生理上更容易发生韧带断裂。哈佛大学学报（Harvard Gazette）2024年12月刊引用的一项最新Meta分析证实了这种差异，该分析显示，女性运动员发生ACL损伤的可能性是男性运动员的1.7倍。如此高的发生率直接转化为对重组手术和医疗设备的持续需求，从而推动了该行业的财务成长。例如，史密斯医疗（Smith & Nephew）在2024年2月报告称，其运动医学关节修復业务在2023年实现了8.8%的潜在收入增长，这主要得益于全球手术数量的激增。

同时に、新规の生物学的植入や再生医疗用スキャフォールドの开発が进み、従来の移植片による重组术の限界を克服することで治疗基准を革新しています。外科医は生体统合技术を积极的に采用し、自体の韧帯を补强することで治癒を促进し、高リスク患者群における再断裂率を大幅に低减しています。こうした革新技术は、再手术のリスクなく负伤前のパフォーマンスレベルに復帰するための耐久性のある解决策を必要とする、若年かつ活动的な患者にとって极めて重要です。この进歩を示す事例として、アースレックス社は2024年12月、自社开発の「InternalBrace」韧帯増强术に関する临床调査において、若年アスリートにおける前十字韧帯（ACL）再断裂リスクが标准修復法と比较して88％低减したことを报告しました。このような进歩は临床成果を向上させ、高品质な修復ソリューションの市场普及を促进し、包括的な生物学的修復への注目を高めています。

市场挑战

由于手术费用高且术后復健必不可少，全球十字韧带修復手术市场面临许多挑战。重组手术涉及大量的费用，包括手术费、住院费和先进的移植技术，而长期且昂贵的物理治疗对于取得良好的治疗效果至关重要。在健保覆盖范围有限或自付费用高的地区，这些费用给患者带来了沉重的经济负担。这种经济压力迫使许多患者，尤其是在对费用敏感的市场和开发中国家，选择非手术治疗或延迟治疗，直接导致手术数量下降。

近期有关伤病治疗成本的数据凸显了这项经济挑战的严峻。根据美国意外伤害赔偿公司 (ACC) 2024 年的报告，20-29 岁年龄层中，标准前十字韧带损伤的平均康復费用约为 14,000 美元。如此高昂的单次治疗费用对许多潜在患者而言构成了巨大的经济障碍。因此，由于经济限制，许多人群无法获得这些旨在恢復关节稳定性的重要手术，从而阻碍了市场扩张。

市场趋势

桥接加强型前十字韧带修復（BEAR）技术的应用，从根本上改变了市场重心，使其从传统的自体重组转向生物修復。与需要采集健康组织进行自体移植的标准方法不同，这种生物工程植入能够保留原有韧带，并利用牛胶原蛋白支架桥接断裂，从而促进人体自身的癒合。由于此方法能够保留本体感觉和原有的解剖结构，因此正迅速被希望避免供体部位併发症的患者所接受。根据2025年3月发布的新闻稿“FDA核准Miach Orthopaedics公司BEAR植入的扩大适应症”，Miach Orthopaedics公司报告称，通过临床试验和商业化，已有超过5000名患者接受了BEAR植入的治疗。

同时，穿戴式感测器在术后照护的应用，正透过实现远端、数据驱动的病患管理，革新復健通讯协定。外科医师正利用互联健康平台，透过即时监测患者的活动范围、步数和依从性，直接应对高成本且管理不善的物理治疗所带来的挑战。这种整合实现了早期疗育和个人化復健路径，显着提升了现代復健解决方案的提案。例如，根据捷迈Biomet公司2025年12月发布的新闻稿《捷迈Biomet与OneStep合作，提供更强大的行动数据》，该公司整合的行动智慧技术目前每天分析超过一百万个步态週期，凸显了用于优化患者疗效的数据规模之庞大。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：十字韧带修復手术的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 手术类型（前十字韧带（ACL）修补、后十字韧带（PCL）修补）
    • 依最终使用者（医院、门诊手术中心等）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美十字韧带修復手术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲十字韧带修復手术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区十字韧带修復手术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲十字韧带修復手术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲十字韧带修復手术市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球十字韧带修復手术市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Zimmer Biomet Holdings Inc
  • Stryker Corp
  • Smith & Nephew plc
  • Arthrex Inc
  • Boston Scientific Corporation
  • B Braun SE
  • athenahealth Inc
  • Wright Medical Group NV

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 21827

The Global Cruciate Ligament Repair Procedures Market is projected to expand from USD 15.06 Billion in 2025 to USD 22.36 Billion by 2031, reflecting a CAGR of 6.81%. These surgical interventions aim to reconstruct damaged anterior or posterior knee ligaments using autografts, allografts, or synthetic substitutes to restore joint stability. The market is primarily propelled by the increasing prevalence of sports-related injuries and higher participation in high-impact physical activities among the general population. For instance, the New Zealand ACL Registry reported in 2024 that rugby remained the leading cause of injury among patients, responsible for 23% of cases, highlighting the direct link between contact sports and the demand for reconstructive surgeries. Additionally, advancements in minimally invasive techniques and graft fixation technologies continue to support market growth by enhancing patient outcomes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 15.06 Billion
Market Size 2031USD 22.36 Billion
CAGR 2026-20316.81%
Fastest Growing SegmentAnterior Cruciate Ligament Repair
Largest MarketNorth America

However, a significant barrier to market expansion is the substantial cost associated with these complex surgeries and the mandatory post-operative rehabilitation. Limited reimbursement coverage in many healthcare systems creates financial obstacles that restrict patient access to advanced treatment options. Furthermore, the potential risks of complications, such as graft failure or infection, necessitate rigorous long-term management, which may discourage cost-sensitive patients from undergoing these essential procedures. These economic factors collectively present a hurdle to the widespread adoption of cruciate ligament repair solutions, particularly within developing markets.

Market Driver

The rising incidence of high-impact sports-related injuries serves as a major catalyst for the expansion of the cruciate ligament repair market, driven by intensifying athletic participation and the competitive nature of modern sports. This trend is particularly evident among female athletes, who are physiologically more prone to ligament ruptures during pivot-heavy activities like soccer and basketball. A recent meta-analysis cited by the Harvard Gazette in December 2024 underscores this disparity, indicating that female athletes sustain anterior cruciate ligament (ACL) injuries at a rate 1.7 times higher than their male counterparts. This elevated frequency translates directly into sustained demand for reconstructive surgeries and medical devices, bolstering the sector's financial trajectory; for example, Smith+Nephew reported in February 2024 that their Sports Medicine Joint Repair business achieved an 8.8% underlying revenue growth in 2023, largely due to the global surge in procedure volumes.

Simultaneously, the development of novel biologic implants and regenerative scaffolds is revolutionizing treatment standards by addressing the limitations of traditional graft reconstructions. Surgeons are increasingly adopting bio-integrative technologies that augment the native ligament, thereby accelerating healing and significantly lowering failure rates in high-risk patient populations. These innovations are critical for younger, active patients who require durable solutions to return to pre-injury performance levels without the setbacks of revision surgery. Illustrating this progress, Arthrex reported in December 2024 that clinical research on their InternalBrace ligament augmentation technique demonstrated an 88% reduction in the risk of ACL retears in young athletes compared to standard repair methods. Such advancements improve clinical outcomes and encourage wider market adoption of premium repair solutions, shifting focus toward comprehensive biological restoration.

Market Challenge

The Global Cruciate Ligament Repair Procedures Market faces a significant obstacle due to the high costs incurred during surgical interventions and the necessary post-operative rehabilitation. Reconstructive procedures involve substantial expenditure on surgical fees, hospital stays, and advanced graft technologies, while successful outcomes rely heavily on prolonged and costly physical therapy. In healthcare systems with limited reimbursement policies or high deductibles, these expenses place a severe financial burden on patients. This economic strain forces many individuals, particularly in cost-sensitive or developing markets, to opt for non-surgical management or delay treatment, thereby directly reducing the volume of procedures performed.

The magnitude of this financial challenge is highlighted by recent data regarding injury management expenses. According to the Accident Compensation Corporation in 2024, the average recovery cost for a standard anterior cruciate ligament injury in the 20 to 29 age demographic was approximately $14,000. This high per-patient cost underscores the affordability gap that exists for many potential candidates. Consequently, market expansion is restricted as economic limitations prevent a wider population from accessing these essential surgeries designed to restore joint stability.

Market Trends

The adoption of Bridge-Enhanced ACL Restoration (BEAR) technology is fundamentally shifting the market focus from traditional graft-based reconstruction to biological restoration. Unlike standard procedures that require harvesting healthy tissue for autografts, this bio-engineered implant preserves the native ligament and utilizes a bovine collagen scaffold to bridge the tear, enabling the body to heal itself. This approach maintains proprioception and native anatomy, driving rapid clinical uptake among patients seeking to avoid donor site morbidity. According to a March 2025 press release titled 'FDA Approves Expanded Use of Miach Orthopaedics' BEAR Implant,' Miach Orthopaedics reported that more than 5,000 patients have been treated with the BEAR Implant through clinical trial and commercial use.

Concurrently, the incorporation of wearable sensors in post-operative care is transforming rehabilitation protocols by enabling remote, data-driven patient management. Surgeons are increasingly leveraging connected health platforms to monitor range of motion, step count, and compliance in real-time, directly addressing the challenge of costly and unmonitored physical therapy. This integration allows for early intervention and personalized recovery pathways, significantly enhancing the value proposition of modern repair solutions. For instance, according to Zimmer Biomet's December 2025 press release, 'Zimmer Biomet, OneStep Collaborate to Provide Enhanced Mobility Data,' their integrated mobility intelligence technology now analyzes more than one million gait cycles every day, underscoring the massive scale of data being utilized to optimize patient outcomes.

Key Market Players

  • Zimmer Biomet Holdings Inc
  • Stryker Corp
  • Smith & Nephew plc
  • Arthrex Inc
  • Boston Scientific Corporation
  • B Braun SE
  • athenahealth Inc
  • Wright Medical Group NV

Report Scope

In this report, the Global Cruciate Ligament Repair Procedures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cruciate Ligament Repair Procedures Market, By Procedure Type

  • Anterior Cruciate Ligament (ACL) Repair
  • Posterior Cruciate Ligament (PCL) Repair

Cruciate Ligament Repair Procedures Market, By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Cruciate Ligament Repair Procedures Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cruciate Ligament Repair Procedures Market.

Available Customizations:

Global Cruciate Ligament Repair Procedures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cruciate Ligament Repair Procedures Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Procedure Type (Anterior Cruciate Ligament (ACL) Repair, Posterior Cruciate Ligament (PCL) Repair)
    • 5.2.2. By End-use (Hospitals, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cruciate Ligament Repair Procedures Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Procedure Type
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cruciate Ligament Repair Procedures Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Procedure Type
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada Cruciate Ligament Repair Procedures Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Procedure Type
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico Cruciate Ligament Repair Procedures Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Procedure Type
        • 6.3.3.2.2. By End-use

7. Europe Cruciate Ligament Repair Procedures Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Procedure Type
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Procedure Type
        • 7.3.1.2.2. By End-use
    • 7.3.2. France Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Procedure Type
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Procedure Type
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Procedure Type
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain Cruciate Ligament Repair Procedures Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Procedure Type
        • 7.3.5.2.2. By End-use

8. Asia Pacific Cruciate Ligament Repair Procedures Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Procedure Type
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Procedure Type
        • 8.3.1.2.2. By End-use
    • 8.3.2. India Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Procedure Type
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Procedure Type
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Procedure Type
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia Cruciate Ligament Repair Procedures Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Procedure Type
        • 8.3.5.2.2. By End-use

9. Middle East & Africa Cruciate Ligament Repair Procedures Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Procedure Type
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cruciate Ligament Repair Procedures Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Procedure Type
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE Cruciate Ligament Repair Procedures Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Procedure Type
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa Cruciate Ligament Repair Procedures Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Procedure Type
        • 9.3.3.2.2. By End-use

10. South America Cruciate Ligament Repair Procedures Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Procedure Type
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cruciate Ligament Repair Procedures Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Procedure Type
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia Cruciate Ligament Repair Procedures Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Procedure Type
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina Cruciate Ligament Repair Procedures Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Procedure Type
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cruciate Ligament Repair Procedures Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zimmer Biomet Holdings Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Stryker Corp
  • 15.3. Smith & Nephew plc
  • 15.4. Arthrex Inc
  • 15.5. Boston Scientific Corporation
  • 15.6. B Braun SE
  • 15.7. athenahealth Inc
  • 15.8. Wright Medical Group NV

16. Strategic Recommendations

17. About Us & Disclaimer